[ET Net News Agency, 15 April 2024] HIGHTIDE-B (02511) rose 39.5% to HK$6, breaking
above the 20-D SMA of HK$5.972.
It hits an intra-day high of HK$6.2, and an intra-day low of HK$4.03. The total shares
traded was 1.22 million, with a value of HK$5.98m. The active buy/sell ratio is 56:44,
with net buying turnover of HK$735,560. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$191,122, with volume weighted average price of
HK$5.089. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of
HK$152,015, with volume weighted average price of HK$4.751. The stock has risen a combined
41.2% over the past 2 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 6.000 % Chg +39.53%
High 6.200 Low 4.030
Shares Tr 1.22m Turnover 5.98m
10-D SMA 5.321 %H.V 114.493
20-D SMA 5.972 VWAP 4.890
50-D SMA 8.819 RSI14 43.853
---------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 56:44, with net buying
turnover of HK$735,560, rising a combined 41.2% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HIGHTIDE-B (02511) 6.00 +39.53
GENSCRIPT BIO (01548) 12.10 -5.17
INNOVENT BIO (01801) 35.75 -4.28
EVEREST MED-B (01952) 24.60 -5.93
LAEKNA-B (02105) 7.79 +61.95
SIRNAOMICS-B (02257) 7.72 +18.77
WUXI BIO (02269) 13.66 -1.73
TIGERMED (03347) 32.60 +1.09
AKESO (09926) 48.10 -2.83
REMEGEN (09995) 28.90 -10.39
---------------------------------------------
(ed)